AzTrials
AzTrials

FibromyalgiafMRI/FMEXNCT02407665

Tai Chi Intervention and Brain Imaging Study Among Fibromyalgia Patients and Healthy Controls

A study testing Tai Chi in people with Fibromyalgia and Chronic Pain, run by Tufts Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This exploratory study proposal is the first pilot brain imaging study to determine if Tai Chi can modulate brain resting state functional connectivity (rsFC) and brain morphometry among fibromyalgia (FM) patients and healthy controls. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Fibromyalgia, Chronic Pain
What is being tested?
Tai Chi
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteUnited States
Study dates
Mar 2015to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 21 years or older.
  • Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for FM: (1) a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist for a minimum duration of 3 months, and (2) pain in 11 or more of 18 specific tender points with moderate or greater tenderness reported upon digital palpation.22
  • Fulfills the ACR 2010 diagnostic criteria for FM: (WPI ≥7 AND SS ≥5) OR (WPI 3-6 AND SS ≥9) and does not have a disorder that would otherwise explain the pain23
  • Willing to complete a 12-week, twice-a-week Tai Chi exercise program.
  • Willing to abstain from Aerobic Exercise or other new formalized exercise programs until completion of the study.
  • Willing to undergo MRI at baseline and follow-up.

Who cannot join

  • Prior experience with Tai Chi or other similar types of Complementary and Alternative Medicine in the past 1 year such as Qi gong and yoga since these share some of the principles of Tai Chi.
  • Dementia, neurological disease, cancer, cardiovascular disease, pulmonary disease, metabolic disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the Tai Chi programs, as determined by the study physicians.
  • Any other diagnosed medical condition known to contribute to FM symptomatology, such as thyroid disease, inflammatory arthritis, systemic lupus erythematosis, rheumatoid arthritis, myositis, vasculitis or Sjogren's syndrome.
  • Inability to pass the Physical Activity Readiness Questionnaire (PAR-Q)
  • Inability to pass the Mini-Mental Status examination (with a score below 24)24 Enrollment in any other clinical trial within the last 30 days
  • Plan to permanently relocate from the region during the trial period
  • Presence of any contraindications to fMRI scanning. Including but not limited to: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy, weight >300 lbs
  • Non-English Speaking.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Tufts Medical Center

    Boston, Massachusetts, 02111

Other trials in United States

About this study

Official title: A Pilot fMRI Study of Fibromyalgia: Tai Chi Intervention

This exploratory study proposal is the first pilot brain imaging study to determine if Tai Chi can modulate brain resting state functional connectivity (rsFC) and brain morphometry among fibromyalgia (FM) patients and healthy controls.

Read the detailed description

Twenty-four FM patients and 24 age matched healthy control will be recruited. All FM patients will undergo Tai Chi intervention twice weekly for 12 weeks of practice. fMRI resting state and brain structure data will be collected before and after treatment. For the healthy control group, the fMRI and structure data will only be collected once, contemporaneous with the 12 week scan for the fibromyalgia patients.

The primary outcome will be rsFC of rostral anterior cingulate cortex (rACC), a key region in descending pain modulatory system (DPMS). The secondary outcome include change of the cortical thickness changes, fibromyalgia symptom severity, widespread pain index, depression, stress/anxiety, sleep quality, and quality of life. Covariates include age, gender, body mass index, disease duration, depression, and comorbidities. Clinical outcome measurements will be collected at baseline and after 12 weeks of intervention for the fibromyalgia cohort and at a single visit for the healthy controls. The Tai Chi classes will be taught at Tufts Medical Center and the fMRI scans will be performed at Massachusetts General Hospital Martinos Center.

The project will advance science in the field of mind-body medicine for chronic pain management, both mechanistically and clinically.

Being tested
Tai Chi
Keywords
Tai Chi, fMRI
Medical subject headings
Fibromyalgia, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tai ChiBehavioural

    Each Tai Chi session will last 60 minutes and will continue twice a week for 12 weeks. Our instructors, who have extensive experience conducting Tai Chi training programs, will follow the standardized Tai Chi protocol. We will also provide the participants with printed materials on FM and the Tai Chi Mind-Body program, including Tai Chi principles, practicing techniques, and safety precautions for participants with FM

Study groups in NCT02407665
Study groupRoleWhat they receive
Tai ChiExperimentalParticipants who practice Tai Chi 2X/week for 12-weeks
Receives: Behavioral: Tai Chi
Healthy ControlNo intervention24 healthy controls

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain Resting State Functional Connectivity as measured by fMRI

    rostral anterior cingulate cortex (rACC), a key region in descending pain modulatory system (DPMS)

    Measured: Modulation of impaired rsFC and brain structure at 12 weeks

Secondary outcomes (10)
  1. Cortical Thickness as measured by fMRI

    Measured: Baseline and 12-week

  2. Fibromyalgia Symptom Severity as measured by FIQR Questionnaire

    FIQR

    Measured: Baseline, weekly, and 12-week

  3. Widespread Pain Index as measured by Clinical Diagnostic Criteria for Fibromyalgia Questionnaire

    Clinical Diagnostic Criteria for Fibromyalgia

    Measured: Baseline and 12-week

  4. Depression as measured by BECK-II Questionnaire

    BECK-II

    Measured: Baseline and 12-week

  5. Stress/Anxiety as measured by Hospital Anxiety and Depression Scale

    Hospital Anxiety and Depression Scale

    Measured: Baseline and 12-week

  6. Sleep Quality as measured by PSQI Questionnaire

    PSQI

    Measured: baseline and 12-week

  7. Quality of Life as measured by visual analog scale and SF-36 Questionnaire

    VAS, SF-36

    Measured: baseline and 12-week

  8. Mindfulness as measured by Five Facet Mindfulness Questionnaire

    FFMQ

    Measured: baseline and 12-week

  9. Self-Efficacy as by Chronic Pain and Self Efficacy Questionnaire

    Chronic Pain Self Efficacy

    Measured: baseline and 12-week

  10. Quantitative Sensory Testing as measured by an Algometer

    Pain threshold

    Measured: baseline and 12-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2015 (estimated)
  2. Study startMar 2015
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02407665
Sponsor's protocol ID
11552
Acronym
fMRI/FMEX
Status last verified
Feb 2016
First submitted
18 Mar 2015
Last updated
10 Feb 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Kong J, Huang Y, Liu J, Yu S, Ming C, Chen H, Wilson G, Harvey WF, Li W, Wang C. Altered functional connectivity between hypothalamus and limbic system in fibromyalgia. Mol Brain. 2021 Jan 20;14(1):17. doi: 10.1186/s13041-020-00705-2.

    PubMed 33472674

Questions about this trial

What is this clinical trial studying?

A study testing Tai Chi in people with Fibromyalgia and Chronic Pain, run by Tufts Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain Resting State Functional Connectivity as measured by fMRI (time frame: Modulation of impaired rsFC and brain structure at 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02407665, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in